T-lymphocyte activation pathways in alcoholic liver disease

Area of Science:

• Immunology
• Hepatology
• Cellular Biology

Background:

• Chronic alcohol abuse is known to cause immune system derangement in patients with liver disease.
• Previous in vitro studies on cellular immune function in these patients yielded conflicting results.
• Advancements in immunological techniques allow for detailed study of T-cell function.

Purpose of the Study:

• To investigate in vitro T-cell hypo-responsiveness in alcoholic liver disease (ALD) patients without malnutrition or cirrhosis.
• To identify specific defects in T-cell activation pathways.
• To explore the underlying mechanisms of immune dysfunction in ALD.

Main Methods:

• Studied lymphocyte transformation using monoclonal antibodies against CD3 and CD2 surface structures.
• Assessed interleukin-2 (IL-2) receptor expression upon in vitro activation.
• Investigated the effects of recombinant IL-2 (rIL-2), rIL-1, phorbol 12-myristate 13-acetate, and Ca2+ ionophore A23187 on T-cell function.
• Analyzed T-cell populations, including naive T cells (CD3+/UCHL1-low) expressing CD45RA.

Main Results:

• ALD patients exhibited a markedly defective CD2 pathway in T lymphocytes.
• Reduced interleukin-2 (IL-2) receptor expression was observed upon in vitro activation.
• The defect was not reversed by rIL-2 or rIL-1, but partially overcome by phorbol 12-myristate 13-acetate, suggesting protein kinase C (PKC) involvement.
• Expanded circulating naive T cells (CD3+/UCHL1-low) expressing CD45RA were found.

Conclusions:

• A significant defect in the CD2 pathway of T lymphocytes exists in ALD patients, independent of malnutrition or cirrhosis.
• Faulty intracellular signal transduction, potentially involving protein kinase C (PKC) and impaired calcium mobilization, underlies the CD2 defect.
• Ethanol may directly affect transmembrane signal transduction, leading to T-cell dysfunction and altered T-cell populations in ALD.